(Registrieren)

EANS-Adhoc: WINCOR NIXDORF Aktiengesellschaft / Market recovery lacks solidity: Wincor Nixdorf lowers forecast and agrees share buyback program

Geschrieben am 04-05-2011

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

6-month report

04.05.2011

Against the backdrop of inconsistent market recovery and in view of
the fact that planned net sales and earnings contributions from
business with high-end systems are not yet achievable in full, Wincor
Nixdorf AG has lowered its forecast for the current fiscal year
2010/2011.

The company now anticipates that it will achieve growth of 4 per
cent in net sales in the current fiscal year 2010/2011, while
operating profit is expected to match or slightly exceed last year's
figure.

At the beginning of the fiscal year, the company had set itself a
target of 6 per cent growth in net sales and 8 per cent in EBITA,
stating that this would be dependent on the speed of recovery within
its markets.

After two quarters of fiscal 2010/2011, Wincor Nixdorf achieved a 4
per cent growth in net sales and an EBITA on previous year´s level.
Given the inconsistent nature of the market recovery, the company´s
previous planned growth in the fiscal year is no longer considered
realistic. With national economies developing, in part at least, at
such widely different speeds, the picture in Wincor Nixdorf´s key
markets is currently one of slow recovery only. Whereas both retail
banks and retailers are now proceeding with system replacements that
had previously been postponed, the scale of investment in larger
streamlining and automation projects is still below anticipated
levels.

Also the Americas region has been unable to match the performance of
the same period in fiscal 2009/2010, during which it had supplied a
large number of high- end systems. Alongside, the company´s new
system generation CINEO, worldwide acclaimed as innovation, has not
yet generated the volume of net sales initially anticipated following
its market launch. So, net sales and earnings contributions from the
business with high-end systems are not realised in full as planned.

With the consent of the Supervisory Board, the Board of Directors of
Wincor Nixdorf AG, passed a resolution to repurchase up to 1,737,569
of the company´s shares on the stock market during the period from
May 04 to September 30, 2011, thus making use of the authorization
granted by the Annual General Meeting on January 24, 2011.

In the case of the approved repurchase of own shares, the purchase
price per share (excluding ancillary costs of purchase) shall deviate
by no more than 10 percent in either direction from the determined
share price in the opening auction of XETRA trading on Frankfurt
Stock Exchange.

The repurchased shares are to be used for all legitimate purposes and
for those covered by the authorization granted by the Annual General
Meeting, in particular, for the purpose of settling obligations
arising from share options to be issued on basis of the authorization
granted by the Annual General Meeting on January 25, 2010 to members
of the Board of Directors, other managers or staff members of the
company and/or subordinated affiliated entities.

Wincor Nixdorf AG currently owns 1,570,929 own shares. Including the
agreed share repurchase own shares will reach 10% of the share
capital.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: WINCOR NIXDORF Aktiengesellschaft
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Andreas Bruck
Telefon: +49(0)5251-693-5200
E-Mail: andreas.bruck@wincor-nixdorf.com

Branche: Computing & Information Technology
ISIN: DE000A0CAYB2
WKN: A0CAYB
Index: MDAX, CDAX, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Hamburg / free trade
Stuttgart / free trade
Hannover / free trade
München / free trade
Berlin / regulated dealing
Düsseldorf / regulated dealing


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

329638

weitere Artikel:
  • EANS-News: Henkel AG & Co. KGaA / Henkel reports solid start to fiscal 2011 -------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- quarterly report/3-month report/Henkel Düsseldorf (euro adhoc) - May 4, 2011 Henkel expects stronger organic sales growth Henkel reports solid start to fiscal 2011 • Sales increase of 8.9 percent to 3,823 million euros (organic: +7.2%) • mehr...

  • EANS-Adhoc: Intercell AG / Intercell starts clinical trial in Pandemic Influenza with its Vaccine Enhancement Patch and provides update to the strategic collaboration with GSK on patches -------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Research & Development 04.05.2011 » Intercell starts a confirmatory clinical study using the Vaccine Enhancement Patch in combination with GSK's H5N1 pandemic Influenza antigen » GSK and Intercell underline mehr...

  • EANS-Adhoc: Intercell AG / Intercell startet klinische Studie für das immunstimmulierende Impfpflaster gegen pandemische Grippe und berichtet über aktuellen Stand der strategischen Allianz mit GSK im -------------------------------------------------------------------------------- Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. -------------------------------------------------------------------------------- Forschung/Entwicklung 04.05.2011 » Intercell startet eine bestätigende, klinische Studie des immunstimmulierenden Impfpflasters "Vaccine Enhancement Patch" (VEP) in Kombination mit dem pandemischen Influenza Antigen H5N1 von mehr...

  • EANS-News: Henkel AG & Co. KGaA / Henkel startet gut in das Geschäftsjahr 2011 -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- Geschäftszahlen/Bilanz/Quartalsbericht/Unternehmen/3-Monatsbericht/He nkel Düsseldorf (euro adhoc) - Henkel erwartet stärkeres organisches Umsatzwachstum Henkel startet gut in das Geschäftsjahr 2011 • Umsatzsteigerung von 8,9 Prozent auf 3.823 Mio. Euro mehr...

  • EANS-News: Agennix AG berichtet über den Geschäftsverlauf im Ersten Quartal 2011 Highlights des Quartals: Abschluss der Patientenaufnahme in Phase III-Studie FORTIS-M und Erhalt eines wichtigen US-Patents für Talactoferrin -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- Quartalsbericht Utl.: Highlights des Quartals: Abschluss der Patientenaufnahme in Phase III-Studie FORTIS-M und Erhalt mehr...

Mehr zu dem Thema Finanzen

Der meistgelesene Artikel zu dem Thema:

Century Casinos wurde in Russell 2000 Index aufgenommen

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht